October 5, 2020 04:56 PM EDTUpdated October 6, 05:43 AM
FDA+

CDER asks FDA to re­voke Mak­e­na's ac­cel­er­at­ed ap­proval less than a week af­ter AM­AG ac­qui­si­tion

Max Gelman

Senior Editor

Just a few days af­ter an­nounc­ing it was be­ing ac­quired for near­ly $650 mil­lion, AM­AG Phar­ma­ceu­ti­cals $AM­AG re­ceived some sour news it’s like­ly been …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

A service from the Financial Times